Monoclonal antibody and taxane

This page covers all Monoclonal antibody and taxane drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting EGFR.

Targets

EGFR

Phase 3 pipeline (1)

• nimotuzumab plus paclitaxel · Biotech Pharmaceutical Co., Ltd. · Oncology
  Nimotuzumab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), while paclitaxel is a taxane that inhibits cell division.